CLINICAL TRIALS PROFILE FOR TOFRANIL-PM
✉ Email this page to a colleague
All Clinical Trials for TOFRANIL-PM
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00296725 ↗ | Dichotic Listening as a Predictor of Medication Response in Depression | Completed | New York State Psychiatric Institute | Phase 1/Phase 2 | 1994-04-01 | Depressed patients will have hearing tests and then be treated with up to three treatments (i.e., Fluoxetine, Imipramine) until remitted, to see whether test results predict specific outcomes. |
| NCT00404755 ↗ | Dichotic Listening as a Predictor of Medication Response in Depression | Completed | New York State Psychiatric Institute | Phase 4 | 2006-07-01 | This study will recruit 100 depressed patients to test whether the previous finding of an association between treatment response (with treatment groups including placebo, imipramine, and fluoxetine) and preferences of hemispheric laterality in perceptual processing are also found with a different type of commonly used anti-depressant, bupropion. |
| NCT00946764 ↗ | To Demonstrate the Relative Bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg Imipramine Hydrochloride Tablets In Healthy Adults Volunteers Under Fasting Conditions | Completed | Sandoz | Phase 1 | 2005-07-01 | To demonstrate the relative bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg imipramine hydrochloride tablets in healthy adult volunteers under fasting conditions. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TOFRANIL-PM
Condition Name
Clinical Trial Locations for TOFRANIL-PM
Trials by Country
Clinical Trial Progress for TOFRANIL-PM
Clinical Trial Phase
Clinical Trial Sponsors for TOFRANIL-PM
Sponsor Name
